A new statistical model may help predict which patients are most likely to receive life-extending benefits from surgical treatment for malignant pleural mesothelioma , according to an article in the September 2015 issue of the Annals of Thoracic Surgery . Younger age, no history of asbestos exposure, epithelioid histology, and a low number of affected lymph nodes were strongly associated with better survival after surgery.
